The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Credit Suisse Downgrades National Grid To Neutral

Thu, 29th May 2014 09:07

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
TRADERS: CREDIT SUISSE CUTS NATIONAL GRID TO 'NEUTRAL' ('OUTPERFORM')
----------
BERENBERG RAISES LEGAL & GENERAL PRICE TARGET TO 265 (250) PENCE - 'BUY'
----------
TRADERS: MERRILL LYNCH RESUMES WEIR GROUP WITH 'BUY' - TARGET 2850 PENCE
----------
NOMURA CUTS TUI TRAVEL PRICE TARGET TO 421 (440) PENCE - 'NEUTRAL'
----------
NOMURA RAISES IMPERIAL TOBACCO PRICE TARGET TO 2250 (2240) PENCE - 'REDUCE'
----------
FTSE 250
----------
BERENBERG INITIATES JOHN WOOD WITH 'HOLD' - TARGET 714 PENCE
----------
BERENBERG INITIATES AMEC WITH 'BUY' - TARGET 1450 PENCE
----------
NOMURA RAISES THOMAS COOK TO 'NEUTRAL' ('REDUCE') - PRICE TARGET 173 (152) PENCE
----------
UBS RAISES IMAGINATION TECHNOLOGIES PRICE TARGET TO 250 (200) PENCE - 'BUY'
----------
UBS CUTS QINETIQ PRICE TARGET TO 215 (235) PENCE - 'NEUTRAL'
----------
UBS RAISES TALK TALK TELECOM TO 'NEUTRAL' ('SELL') - TARGET 310 (235) PENCE
----------
JPMORGAN CUTS DE LA RUE PRICE TARGET TO 850 (854) PENCE - 'NEUTRAL'
----------
HSBC CUTS ICAP PRICE TARGET TO 380 (410) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES GO-AHEAD GROUP PRICE TARGET TO 2535 (2290) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 1830 (1720) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
JPMORGAN RAISES DAILY MAIL PRICE TARGET TO 985 (850) PENCE - 'NEUTRAL'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.